Kidney Week 2025 Conservative Dialysis Management Shortens AKI Recovery With indications that ‘“dialysis begets dialysis”’ and can obscure kidney function improvement, a novel trial shows notable ...
AANEM 2025 Durable Benefit for Nipocalimab in gMG Across Age Groups Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback